ro retatrutide (LY3437943) | GCGR/GLP-1R Inhibitor Retatrutide 20mg
Description
At the beginning of the year, Becton, Dickinson announced it would invest $110 million to expand its production capacity for prefillable syringes to support the rising demand for GLP-1 drugs
New generation antidepressants for depression in children and adolescents: a network meta-analysis
Combined protocols are community-derived from each compound's Phase 2/3 data plus CagriSema rationale
JMIR Res Protoc 13: e62667, 2024
